Plante Moran Financial Advisors, LLC Incyte Corp Transaction History

Plante Moran Financial Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$66.02 - $79.71 $2,574 - $3,108	-39 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$63.34 - $74.11 $2,470 - $2,890	39 New	39 $3,000
Q4 2019 Feb 14, 2020	SELL	$73.04 - $95.72 $6,062 - $7,944	-83 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$72.82 - $86.52 $6,044 - $7,181	83 New	83 $0
Q3 2018 Nov 09, 2018	SELL	$61.75 - $74.23 $2,037 - $2,449	-33 Closed	0 $0
Q2 2018 Jul 26, 2018	BUY	$60.85 - $83.98 $2,008 - $2,771	33 New	33 $2,000

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.